But the point stands: “in the United States” in 102(e) means “in the United States”.
In my opinion that reasoning is too glib. 119(a) says that the foreign application "shall have the same effect as the same application would have if filed in this country." 119(a) does include a carve out that prevents foreign priority from being used to overcome 102(b) rejections, but it is not clear that "same effect" should not also be applied to 102(e). I would suggest that under in re Hilmer, foreign applications do not have the same effect as if filed in this country.
One reason that in re Hilmer is not so straight forward is because the court was attempting to figure out what Congress actually intended. I'm not convinced that the court arrived at the right answer.
Applicant of the application ur about to allow gets the benefit of sec. 119, the “prior art” does not (defensive vs. offensive use of a priority date - well settled law). If that antedating PA patent
published anywhere before the priority date, apply it under 102(a) or (b) as the case may be! If it didn’t, it ain’t PA in the US of A. IMO not “mumbo-jumbo”, judicial construction of a statute, not an aberration. Somebody gets a patent in the US, somebody else gets a patent in Switzerland. UR a US Examiner. What happens in CH ain't ur problem
Is it true that 102(e) is going out the window soon, maybe because of crazy aberations like this? Hmmm, I reviewed sec. 3 of the AIA again. I find no repeal of 35 USC 102(e)
per se. But “before the invention” escape hatch via an interference will be gone.
I enjoy and appreciate the participation of the Examining Corps in this forum. But of course you gota get ur legal advice from the Office of the Solicitor.
[/quote]